首页 > 最新文献

International Journal of Psychiatry in Clinical Practice最新文献

英文 中文
Does attention deficit hyperactivity disorder worsen family functioning and parenting styles? A case control study. 注意缺陷多动障碍会恶化家庭功能和养育方式吗?病例对照研究。
IF 3 4区 医学 Q2 PSYCHIATRY Pub Date : 2024-03-01 Epub Date: 2023-11-28 DOI: 10.1080/13651501.2023.2283221
Mehmet Karadağ, Gizem Yılmaz Saygılı, Zehra Topal Hangül, Fatma Subaşı Turgut

Objective: A bidirectional relationship between family functioning and parenting styles and Attention Deficit and Hyperactivity Disorder (ADHD) is proposed. The aim of this study is to examine the effect of ADHD symptoms on parenting styles and the general functionality of the family as well as symptoms of depression and anxiety.

Methods: 73 children with ADHD (56%) and 56 controls (43%) (a total of 129 participants, 31% female, 69% male) with a mean age of 11.3 (7-17, n: 129) were included in the study, which was conducted in Gaziantep University Hospital Child Psychiatry Department in 2022. The participants completed psychometric scales.

Results: Parents of children with ADHD showed higher positive parenting scores than the control group (p < 0.05). Inconsistent discipline scores were substantially higher in the ADHD combined subtype (14.38 ± 5.2) than in the attention deficit dominant group (17.59 ± 3.96) In addition, a strong correlation was found between familial functionality scores and ADHD severity in the ADHD attention deficit dominant subtype (r:0.601; p:0.027) and as ADHD severity increased, family functionality decreased.

Conclusions: This study shows that parents of children with ADHD have different parenting styles and ADHD affects the overall functionality of the family in the Turkish sample.

目的:探讨家庭功能与父母教养方式与注意缺陷多动障碍(ADHD)之间的双向关系。本研究的目的是研究ADHD症状对父母教养方式、家庭整体功能以及抑郁和焦虑症状的影响。方法:研究于2022年在加济安泰普大学医院儿童精神科进行的73例ADHD患儿(56%)和56例对照组(43%)(共129名参与者,其中女性31%,男性69%),平均年龄11.3岁(7-17岁,n: 129)。参与者完成了心理测量量表。结论:本研究表明,ADHD儿童的父母有不同的养育方式,ADHD影响了土耳其样本中家庭的整体功能。
{"title":"Does attention deficit hyperactivity disorder worsen family functioning and parenting styles? A case control study.","authors":"Mehmet Karadağ, Gizem Yılmaz Saygılı, Zehra Topal Hangül, Fatma Subaşı Turgut","doi":"10.1080/13651501.2023.2283221","DOIUrl":"10.1080/13651501.2023.2283221","url":null,"abstract":"<p><strong>Objective: </strong>A bidirectional relationship between family functioning and parenting styles and Attention Deficit and Hyperactivity Disorder (ADHD) is proposed. The aim of this study is to examine the effect of ADHD symptoms on parenting styles and the general functionality of the family as well as symptoms of depression and anxiety.</p><p><strong>Methods: </strong>73 children with ADHD (56%) and 56 controls (43%) (a total of 129 participants, 31% female, 69% male) with a mean age of 11.3 (7-17, n: 129) were included in the study, which was conducted in Gaziantep University Hospital Child Psychiatry Department in 2022. The participants completed psychometric scales.</p><p><strong>Results: </strong>Parents of children with ADHD showed higher positive parenting scores than the control group (<i>p</i> < 0.05). Inconsistent discipline scores were substantially higher in the ADHD combined subtype (14.38 ± 5.2) than in the attention deficit dominant group (17.59 ± 3.96) In addition, a strong correlation was found between familial functionality scores and ADHD severity in the ADHD attention deficit dominant subtype (r:0.601; p:0.027) and as ADHD severity increased, family functionality decreased.</p><p><strong>Conclusions: </strong>This study shows that parents of children with ADHD have different parenting styles and ADHD affects the overall functionality of the family in the Turkish sample.</p>","PeriodicalId":14351,"journal":{"name":"International Journal of Psychiatry in Clinical Practice","volume":" ","pages":"2-8"},"PeriodicalIF":3.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138444654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hoarding behaviour: special features and complications in real-world clinical practice. 囤积行为:现实世界临床实践中的特殊特征和并发症。
IF 3 4区 医学 Q2 PSYCHIATRY Pub Date : 2024-03-01 Epub Date: 2023-11-29 DOI: 10.1080/13651501.2023.2287755
David Córcoles, Lucía Guerrero, Angeles Malagon, Magda Bellsolà, Ana Maria Gonzalez, Jordi León, Agnès Sabaté, Victor Pérez, Antoni Bulbena, Luis Miguel Martín, Anna Mane

Objective: Hoarding behaviour is a common but poorly characterised problem in real-world clinical practice. Although hoarding behaviour is the key component of Hoarding Disorder (HD), there are people who exhibit hoarding behaviour but do not suffer from HD. The aim of the present study was to characterise a clinical sample of patients with clinically relevant hoarding behaviour and evaluate the differential characteristics between patients with and without HD.

Methods: This study included patients who received treatment at the home visitation program in Barcelona (Spain) from January 2013 through December 2020, and scored ≥ 4 on the Clutter Image Rating scale. Sociodemographic, DSM-5 diagnosis, clinical data and differences between patients with and without an HD diagnosis were assessed.

Results: A total of 243 subjects were included. Hoarding behaviour had been unnoticed in its early stages and the median length in the sample was 10 years (IQR 15). 100% of the cases had hoarding-related complications. HD was the most common diagnosis in 117 patients (48.1%).

Conclusions: The study found several differential characteristics between patients with and without HD diagnosis. Alcohol use disorder could play an important role among those without HD diagnosis. Home visitation programs could improve earlier detection, preventing hoarding-related complications.

目的:囤积行为是现实世界临床实践中常见但特征不明显的问题。尽管囤积行为是囤积症(HD)的关键组成部分,但也有一些人表现出囤积行为,但并不患有囤积症。本研究的目的是描述临床相关囤积行为患者的临床样本,并评估HD患者和非HD患者之间的差异特征。方法:本研究纳入2013年1月至2020年12月在西班牙巴塞罗那接受家访项目治疗的杂乱图像评定量表得分≥4分的患者。评估了社会人口学、DSM-5诊断、临床数据以及确诊和未确诊HD患者之间的差异。结果:共纳入受试者243例。囤积行为在其早期阶段未被注意到,样本的中位数长度为10年(IQR 15)。100%的病例都有囤积相关的并发症。117例患者(48.1%)中HD是最常见的诊断。结论:该研究发现了HD患者和未确诊患者之间的几个差异特征。酒精使用障碍可能在没有HD诊断的人群中发挥重要作用。家访计划可以提高早期发现,防止囤积相关的并发症。
{"title":"Hoarding behaviour: special features and complications in real-world clinical practice.","authors":"David Córcoles, Lucía Guerrero, Angeles Malagon, Magda Bellsolà, Ana Maria Gonzalez, Jordi León, Agnès Sabaté, Victor Pérez, Antoni Bulbena, Luis Miguel Martín, Anna Mane","doi":"10.1080/13651501.2023.2287755","DOIUrl":"10.1080/13651501.2023.2287755","url":null,"abstract":"<p><strong>Objective: </strong>Hoarding behaviour is a common but poorly characterised problem in real-world clinical practice. Although hoarding behaviour is the key component of Hoarding Disorder (HD), there are people who exhibit hoarding behaviour but do not suffer from HD. The aim of the present study was to characterise a clinical sample of patients with clinically relevant hoarding behaviour and evaluate the differential characteristics between patients with and without HD.</p><p><strong>Methods: </strong>This study included patients who received treatment at the home visitation program in Barcelona (Spain) from January 2013 through December 2020, and scored ≥ 4 on the Clutter Image Rating scale. Sociodemographic, DSM-5 diagnosis, clinical data and differences between patients with and without an HD diagnosis were assessed.</p><p><strong>Results: </strong>A total of 243 subjects were included. Hoarding behaviour had been unnoticed in its early stages and the median length in the sample was 10 years (IQR 15). 100% of the cases had hoarding-related complications. HD was the most common diagnosis in 117 patients (48.1%).</p><p><strong>Conclusions: </strong>The study found several differential characteristics between patients with and without HD diagnosis. Alcohol use disorder could play an important role among those without HD diagnosis. Home visitation programs could improve earlier detection, preventing hoarding-related complications.</p>","PeriodicalId":14351,"journal":{"name":"International Journal of Psychiatry in Clinical Practice","volume":" ","pages":"17-26"},"PeriodicalIF":3.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138451456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and risk factors for metabolic syndrome in schizophrenia, schizoaffective, and bipolar disorder. 精神分裂症、情感分裂症和双相情感障碍中代谢综合征的患病率和风险因素。
IF 3 4区 医学 Q2 PSYCHIATRY Pub Date : 2024-03-01 Epub Date: 2024-02-08 DOI: 10.1080/13651501.2024.2310847
Hind Mohd Ahmed, Karim Abdel Aziz, Abeer Al Ammari, Mohammed Galadari, Aaisha Alsaadi, Aysha Alhassani, Fatima Al Marzooqi, Mohammed AlAhbabi, Hind Alsheryani, Meera Bahayan, Reem Ahmed, Sara Alameri, Emmanuel Stip, Dina Aly El-Gabry

Background: Metabolic Syndrome (MetS) is a risk for developing cardiovascular diseases and its prevalence is especially high in psychiatric patients. To date, there is limited data from the United Arab Emirates (UAE) on the prevalence of MetS. Therefore, we aimed to investigate its prevalence and possible risk factors in a large sample of psychiatric patients in the UAE.

Methods: A cross-sectional study was conducted at Al-Ain Hospital, in Al-Ain City, UAE. We collected demographic and clinical data on patients diagnosed with schizophrenia, schizoaffective, and bipolar affective disorder in the period between January 2017 and December 2020. This included their secondary diagnosis (psychiatric or medical), vital signs (heart rate, systolic and diastolic blood pressure, Body Mass Index [BMI]), metabolic parameters (fasting blood glucose, cholesterol, triglycerides, low-density lipoprotein, high-density lipoproteins), and prescribed medications. We used the American Association of Clinical Endocrinology (AACE) criteria to diagnose MetS.

Results: We included 889 subjects and of these, 79.8% (N = 709) had a BMI ≥25 kg/m2 and 9.8% (N = 87) had no abnormal metabolic parameters. Overall, 28.1% (N = 250) had MetS with no statistical difference between the three groups. Fasting blood glucose levels and abnormally elevated triglycerides were significant predictors for MetS.

Conclusion: Our study found that around one in three patients had MetS irrespective of the three diagnoses. Some variables were significant predictors for MetS. Our findings were consistent with other studies and warrant the need for regular screening and management of abnormal metabolic parameters.

背景:代谢综合征(MetS)是心血管疾病的高危因素,在精神病患者中的发病率尤其高。迄今为止,阿拉伯联合酋长国(UAE)有关代谢综合征患病率的数据十分有限。因此,我们旨在对阿联酋精神病患者的患病率和可能的风险因素进行大样本调查:我们在阿联酋艾因市的艾因医院开展了一项横断面研究。我们收集了 2017 年 1 月至 2020 年 12 月期间被诊断为精神分裂症、情感分裂症和双相情感障碍患者的人口统计学和临床数据。其中包括他们的辅助诊断(精神科或内科)、生命体征(心率、收缩压和舒张压、体重指数 [BMI])、代谢参数(空腹血糖、胆固醇、甘油三酯、低密度脂蛋白、高密度脂蛋白)和处方药物。我们采用美国临床内分泌协会(AACE)的标准来诊断 MetS:我们纳入了 889 名受试者,其中 79.8%(N = 709)的体重指数≥25 kg/m2,9.8%(N = 87)的代谢参数无异常。总体而言,28.1%(N = 250)的人患有 MetS,三组之间无统计学差异。空腹血糖水平和甘油三酯异常升高是 MetS 的重要预测因素:我们的研究发现,无论三种诊断结果如何,约三分之一的患者患有 MetS。一些变量是 MetS 的重要预测因素。空腹血糖水平和甘油三酯异常升高是代谢综合征的重要预测因素。代谢指标的筛查以及抗精神病药物的谨慎选择都很重要。
{"title":"Prevalence and risk factors for metabolic syndrome in schizophrenia, schizoaffective, and bipolar disorder.","authors":"Hind Mohd Ahmed, Karim Abdel Aziz, Abeer Al Ammari, Mohammed Galadari, Aaisha Alsaadi, Aysha Alhassani, Fatima Al Marzooqi, Mohammed AlAhbabi, Hind Alsheryani, Meera Bahayan, Reem Ahmed, Sara Alameri, Emmanuel Stip, Dina Aly El-Gabry","doi":"10.1080/13651501.2024.2310847","DOIUrl":"10.1080/13651501.2024.2310847","url":null,"abstract":"<p><strong>Background: </strong>Metabolic Syndrome (MetS) is a risk for developing cardiovascular diseases and its prevalence is especially high in psychiatric patients. To date, there is limited data from the United Arab Emirates (UAE) on the prevalence of MetS. Therefore, we aimed to investigate its prevalence and possible risk factors in a large sample of psychiatric patients in the UAE.</p><p><strong>Methods: </strong>A cross-sectional study was conducted at Al-Ain Hospital, in Al-Ain City, UAE. We collected demographic and clinical data on patients diagnosed with schizophrenia, schizoaffective, and bipolar affective disorder in the period between January 2017 and December 2020. This included their secondary diagnosis (psychiatric or medical), vital signs (heart rate, systolic and diastolic blood pressure, Body Mass Index [BMI]), metabolic parameters (fasting blood glucose, cholesterol, triglycerides, low-density lipoprotein, high-density lipoproteins), and prescribed medications. We used the American Association of Clinical Endocrinology (AACE) criteria to diagnose MetS.</p><p><strong>Results: </strong>We included 889 subjects and of these, 79.8% (<i>N</i> = 709) had a BMI ≥25 kg/m<sup>2</sup> and 9.8% (<i>N</i> = 87) had no abnormal metabolic parameters. Overall, 28.1% (<i>N</i> = 250) had MetS with no statistical difference between the three groups. Fasting blood glucose levels and abnormally elevated triglycerides were significant predictors for MetS.</p><p><strong>Conclusion: </strong>Our study found that around one in three patients had MetS irrespective of the three diagnoses. Some variables were significant predictors for MetS. Our findings were consistent with other studies and warrant the need for regular screening and management of abnormal metabolic parameters.</p>","PeriodicalId":14351,"journal":{"name":"International Journal of Psychiatry in Clinical Practice","volume":" ","pages":"35-44"},"PeriodicalIF":3.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139702453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of bright light therapy on irritability in bipolar depression: a single-blind randomised control trial. 强光疗法对双相抑郁患者易怒的影响:一项单盲随机对照试验。
IF 3 4区 医学 Q2 PSYCHIATRY Pub Date : 2023-11-01 Epub Date: 2023-06-12 DOI: 10.1080/13651501.2023.2221286
Lorenzo Fregna, Francesco Attanasio, Cristina Colombo

Objective: The symptom-complex irritability, widely used in descriptions of bipolar patients' manic and mixed states, also represents a common feature in depressive phases. Irritability negatively affects the clinical course of depression, leading to a higher risk of treatment non-adherence, violence, and suicide attempts. Nevertheless, proportional attention from the scientific literature seems to be scarce. We conducted the first randomised controlled trial with the aim of evaluating BLT as a possible therapeutic strategy for irritability in bipolar depression.

Methods: 180 inpatients were randomly assigned to: Group A exposed to bright light therapy (BLT) daily, or Group B treated with pharmacotherapy only. A qualitative assessment of irritability was performed after a 4-week program.

Results: Group A showed about one-third fewer cases of irritability compared to Group B, this reduction was not related to the overall remission of depressive symptoms.

Conclusions: The present study supports the usefulness of BLT in irritability in bipolar depression.

目的:症状复杂易怒广泛用于描述双相情感障碍患者的躁狂和混合状态,也是抑郁期的一个常见特征。易怒会对抑郁症的临床进程产生负面影响,导致治疗不依从、暴力和自杀未遂的风险更高。然而,科学文献的关注似乎很少。我们进行了第一项随机对照试验,目的是评估BLT作为治疗双相抑郁症易怒的可能策略。方法:180例住院患者被随机分为:A组每天接受强光治疗,B组仅接受药物治疗。在为期4周的项目后,对易怒进行了定性评估。结果:与B组相比,A组的易怒病例减少了约三分之一,这种减少与抑郁症状的总体缓解无关。结论:本研究支持BLT在双相抑郁易激惹中的作用。
{"title":"The effect of bright light therapy on irritability in bipolar depression: a single-blind randomised control trial.","authors":"Lorenzo Fregna,&nbsp;Francesco Attanasio,&nbsp;Cristina Colombo","doi":"10.1080/13651501.2023.2221286","DOIUrl":"10.1080/13651501.2023.2221286","url":null,"abstract":"<p><strong>Objective: </strong>The symptom-complex irritability, widely used in descriptions of bipolar patients' manic and mixed states, also represents a common feature in depressive phases. Irritability negatively affects the clinical course of depression, leading to a higher risk of treatment non-adherence, violence, and suicide attempts. Nevertheless, proportional attention from the scientific literature seems to be scarce. We conducted the first randomised controlled trial with the aim of evaluating BLT as a possible therapeutic strategy for irritability in bipolar depression.</p><p><strong>Methods: </strong>180 inpatients were randomly assigned to: Group A exposed to bright light therapy (BLT) daily, or Group B treated with pharmacotherapy only. A qualitative assessment of irritability was performed after a 4-week program.</p><p><strong>Results: </strong>Group A showed about one-third fewer cases of irritability compared to Group B, this reduction was not related to the overall remission of depressive symptoms.</p><p><strong>Conclusions: </strong>The present study supports the usefulness of BLT in irritability in bipolar depression.</p>","PeriodicalId":14351,"journal":{"name":"International Journal of Psychiatry in Clinical Practice","volume":" ","pages":"416-418"},"PeriodicalIF":3.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9987208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Depression and atrial fibrillation in a reciprocal liaison: a neuro-cardiac link. 抑郁和心房颤动的相互联系:神经-心脏联系。
IF 3 4区 医学 Q2 PSYCHIATRY Pub Date : 2023-11-01 Epub Date: 2023-08-24 DOI: 10.1080/13651501.2023.2248214
Theodora A Manolis, Antonis A Manolis, Evdoxia J Apostolopoulos, Helen Melita, Antonis S Manolis

Objective: To explore the reciprocal relationship of depression and atrial fibrillation (AF).

Methods: A literature search was conducted in Pub Med, Scopus, and Google Scholar using relevant terms for depression and AF and respective therapies.

Results: There is evidence that depression is involved in the aetiology and prognosis of AF. AF, independently of its type, incurs a risk of depression in 20-40% of patients. Also, depression significantly increases cumulative incidence of AF (from 1.92% to 4.44% at 10 years); 25% increased risk of new-onset AF is reported in patients with depression, reaching 32% in recurrent depression. Hence, emphasis is put on the importance of assessing depression in the evaluation of AF and vice versa. Persistent vs paroxysmal AF patients may suffer from more severe depression. Furthermore, depression can impact the effectiveness of AF treatments, including pharmacotherapy, anticoagulation, cardioversion and catheter ablation.

Conclusions: A reciprocal association of depression and AF, a neurocardiac link, has been suggested. Thus, strategies which can reduce depression may improve AF patients' course and treatment outcomes. Also, AF has a significant impact on risk of depression and quality of life. Hence, effective antiarrhythmic therapies may alleviate patients' depressive symptoms. KEY POINTSAF, independently of its type of paroxysmal, permanent or chronic, appears to have mental besides physical consequences, including depression and anxietyA reciprocal influence or bidirectional association of depression and AF, a neurocardiac link, has been suggestedAF has considerable impact on the risk of depression occurrence with 20-40% of patients with AF found to have high levels of depressionAlso, depression significantly increases 10-year cumulative incidence and risk of AF from 1.92% to 4.44% in people without depression, and the risk of new-onset AF by 25-32%Emphasis should be placed on the importance of assessing depression in the evaluation of AF and vice versaPersistent/chronic AF patients may suffer from more severe depressed mood than paroxysmal AF patients with similar symptom burdenDepression and anxiety can impact the effectiveness of certain AF treatments, including pharmacotherapy, anticoagulation treatment, cardioversion and catheter ablationThus, strategies which can reduce anxiety and depression may improve AF patients' course and treatment outcomesAlso, effective antiarrhythmic therapies to control AF may alleviate patients' depressive mood.

目的:探讨抑郁症与心房颤动(AF)的相互关系。方法:在Pub Med、Scopus和Google Scholar上检索抑郁症和AF的相关术语以及各自的治疗方法。结果:有证据表明抑郁症与房颤的病因和预后有关。房颤,无论其类型如何,20-40%的患者都有患抑郁症的风险。此外,抑郁症显著增加了房颤的累计发病率(从1.92%增加到4.44% 年);据报道,抑郁症患者新发AF的风险增加25%,复发性抑郁症患者增加32%。因此,在AF评估中,强调评估抑郁的重要性,反之亦然。持续性房颤与阵发性房颤患者可能会患上更严重的抑郁症。此外,抑郁症会影响房颤治疗的有效性,包括药物治疗、抗凝、心脏复律和导管消融。结论:抑郁症和房颤(一种神经-心脏联系)之间存在相互关联。因此,减少抑郁的策略可以改善房颤患者的病程和治疗结果。此外,房颤对抑郁症的风险和生活质量也有显著影响。因此,有效的抗心律失常治疗可以缓解患者的抑郁症状。关键点AF,独立于其发作性、永久性或慢性类型,似乎有精神和身体上的后果,包括抑郁和焦虑。抑郁和AF的相互影响或双向关联,一种神经心联系,有人认为,房颤对抑郁症发生的风险有相当大的影响,20-40%的房颤患者患有高水平的抑郁症。此外,在没有抑郁症的人中,抑郁症显著增加了10年累计房颤发生率和风险,从1.92%增加到4.44%,新发性房颤的风险增加25-32%。在评估房颤时,应强调评估抑郁的重要性,反之亦然。持续性/慢性房颤患者可能比具有类似症状负担的阵发性房颤患者遭受更严重的抑郁情绪。抑郁和焦虑会影响某些房颤治疗的有效性,包括药物治疗,抗凝治疗、心脏复律和导管消融因此,减少焦虑和抑郁的策略可以改善房颤患者的病程和治疗结果。此外,有效的抗心律失常治疗可以缓解患者的抑郁情绪。
{"title":"Depression and atrial fibrillation in a reciprocal liaison: a neuro-cardiac link.","authors":"Theodora A Manolis,&nbsp;Antonis A Manolis,&nbsp;Evdoxia J Apostolopoulos,&nbsp;Helen Melita,&nbsp;Antonis S Manolis","doi":"10.1080/13651501.2023.2248214","DOIUrl":"10.1080/13651501.2023.2248214","url":null,"abstract":"<p><strong>Objective: </strong>To explore the reciprocal relationship of depression and atrial fibrillation (AF).</p><p><strong>Methods: </strong>A literature search was conducted in Pub Med, Scopus, and Google Scholar using relevant terms for depression and AF and respective therapies.</p><p><strong>Results: </strong>There is evidence that depression is involved in the aetiology and prognosis of AF. AF, independently of its type, incurs a risk of depression in 20-40% of patients. Also, depression significantly increases cumulative incidence of AF (from 1.92% to 4.44% at 10 years); 25% increased risk of new-onset AF is reported in patients with depression, reaching 32% in recurrent depression. Hence, emphasis is put on the importance of assessing depression in the evaluation of AF and vice versa. Persistent vs paroxysmal AF patients may suffer from more severe depression. Furthermore, depression can impact the effectiveness of AF treatments, including pharmacotherapy, anticoagulation, cardioversion and catheter ablation.</p><p><strong>Conclusions: </strong>A reciprocal association of depression and AF, a neurocardiac link, has been suggested. Thus, strategies which can reduce depression may improve AF patients' course and treatment outcomes. Also, AF has a significant impact on risk of depression and quality of life. Hence, effective antiarrhythmic therapies may alleviate patients' depressive symptoms. KEY POINTSAF, independently of its type of paroxysmal, permanent or chronic, appears to have mental besides physical consequences, including depression and anxietyA reciprocal influence or bidirectional association of depression and AF, a neurocardiac link, has been suggestedAF has considerable impact on the risk of depression occurrence with 20-40% of patients with AF found to have high levels of depressionAlso, depression significantly increases 10-year cumulative incidence and risk of AF from 1.92% to 4.44% in people without depression, and the risk of new-onset AF by 25-32%Emphasis should be placed on the importance of assessing depression in the evaluation of AF and vice versaPersistent/chronic AF patients may suffer from more severe depressed mood than paroxysmal AF patients with similar symptom burdenDepression and anxiety can impact the effectiveness of certain AF treatments, including pharmacotherapy, anticoagulation treatment, cardioversion and catheter ablationThus, strategies which can reduce anxiety and depression may improve AF patients' course and treatment outcomesAlso, effective antiarrhythmic therapies to control AF may alleviate patients' depressive mood.</p>","PeriodicalId":14351,"journal":{"name":"International Journal of Psychiatry in Clinical Practice","volume":" ","pages":"397-415"},"PeriodicalIF":3.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10050936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Episodic obsessive-compulsive disorder and bipolar spectrum disorder: new evidence from a large Italian OCD sample. 情景性强迫症和双相情感障碍:来自意大利强迫症大样本的新证据。
IF 3 4区 医学 Q2 PSYCHIATRY Pub Date : 2023-11-01 Epub Date: 2023-07-04 DOI: 10.1080/13651501.2023.2231040
Stefano Bramante, Sylvia Rigardetto, Roberta Borgogno, Emina Mehanović, Luca Pellegrini, Umberto Albert, Giuseppe Maina

Objectives: Obsessive-Compulsive Disorder (OCD) has been considered to be a chronic illness; however, some authors described a subtype of OCD characterised by symptom-free periods of time: Episodic-OCD (E-OCD). Only few studies focussed on this subtype of the disorder. The objectives of this research were to study the association between the episodic course of the disorder and lifetime psychiatric comorbidities and to investigate socio-demographic and other clinical features correlated to the episodic course.

Methods: The sample is composed of adult OCD patients. The course was defined episodic when at least one circumscribed symptom-free interval of at least 6 months was present. The sample was divided into two subgroups: Episodic-OCD and Chronic-OCD. Differences between groups were analysed with Student's t-test, χ2 tests, Fisher test and multivariate logistic regression.

Results: Data regarding 585 individuals were collected. 14.2% (N = 83) of our sample had an episodic course. Bipolar I comorbid disorder, abrupt onset, lower severity of illness and lower rates of repeating compulsions were associated with the likelihood of having an E-OCD.

Conclusions: Our findings confirm that a significant proportion of OCD patients have an episodic course and that E-OCD could represent a specific endophenotype.

目的:强迫症被认为是一种慢性疾病;然而,一些作者描述了一种以无症状时间段为特征的强迫症亚型:发作性强迫症(E-OCD)。只有很少的研究关注这种亚型的疾病。本研究的目的是研究该疾病的发作过程与终生精神病合并症之间的关系,并调查与发作过程相关的社会人口学和其他临床特征。方法:样本由成年强迫症患者组成。当至少有一个限定的无症状间隔至少为6时,该过程被定义为偶发性 有几个月的时间。样本被分为两个亚组:发作性强迫症和慢性强迫症。采用Student t检验、χ2检验、Fisher检验和多元逻辑回归分析各组间的差异。结果:收集了585名个体的数据。14.2%(N = 83)具有偶发性过程。双相I型共病障碍、突然发作、疾病严重程度较低和重复强迫发生率较低与患强迫症的可能性有关。结论:我们的研究结果证实,很大一部分强迫症患者有发作性病程,强迫症可能代表一种特定的内表型。
{"title":"Episodic obsessive-compulsive disorder and bipolar spectrum disorder: new evidence from a large Italian OCD sample.","authors":"Stefano Bramante,&nbsp;Sylvia Rigardetto,&nbsp;Roberta Borgogno,&nbsp;Emina Mehanović,&nbsp;Luca Pellegrini,&nbsp;Umberto Albert,&nbsp;Giuseppe Maina","doi":"10.1080/13651501.2023.2231040","DOIUrl":"10.1080/13651501.2023.2231040","url":null,"abstract":"<p><strong>Objectives: </strong>Obsessive-Compulsive Disorder (OCD) has been considered to be a chronic illness; however, some authors described a subtype of OCD characterised by symptom-free periods of time: Episodic-OCD (E-OCD). Only few studies focussed on this subtype of the disorder. The objectives of this research were to study the association between the episodic course of the disorder and lifetime psychiatric comorbidities and to investigate socio-demographic and other clinical features correlated to the episodic course.</p><p><strong>Methods: </strong>The sample is composed of adult OCD patients. The course was defined episodic when at least one circumscribed symptom-free interval of at least 6 months was present. The sample was divided into two subgroups: Episodic-OCD and Chronic-OCD. Differences between groups were analysed with Student's t-test, χ2 tests, Fisher test and multivariate logistic regression.</p><p><strong>Results: </strong>Data regarding 585 individuals were collected. 14.2% (<i>N</i> = 83) of our sample had an episodic course. Bipolar I comorbid disorder, abrupt onset, lower severity of illness and lower rates of repeating compulsions were associated with the likelihood of having an E-OCD.</p><p><strong>Conclusions: </strong>Our findings confirm that a significant proportion of OCD patients have an episodic course and that E-OCD could represent a specific endophenotype.</p>","PeriodicalId":14351,"journal":{"name":"International Journal of Psychiatry in Clinical Practice","volume":" ","pages":"330-337"},"PeriodicalIF":3.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9750087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Which clinical factors and biochemical parameters are associated with late-life major depression? 哪些临床因素和生化参数与晚期抑郁症有关?
IF 3 4区 医学 Q2 PSYCHIATRY Pub Date : 2023-11-01 Epub Date: 2023-11-07 DOI: 10.1080/13651501.2023.2260426
Massimiliano Buoli, Francesca Legnani, Guido Nosari, Anna Pan, Valentina Ciappolino, Cecilia Maria Esposito, Alessandro Ceresa, Martina Di Paolo, Teresa Surace, Anna Maria Auxilia, Martina Capellazzi, Ilaria Tagliabue, Luisa Cirella, Francesco Zanelli Quarantini, Antonios Dakanalis, Massimo Clerici, Enrico Capuzzi, Alice Caldiroli

Introduction: Late-life major depression (MD) is a frequent and high-cost psychiatric disorder. Our purpose was to detect clinical and biological factors possibly associated with this condition to better prevent and treat it.

Methods: We recruited 343 patients, consecutively admitted for a Major Depressive Episode to the inpatient clinic of Policlinico of Milan and ASST Monza, Italy. A large set of clinical and biochemical variables was collected from clinical charts. Univariate analyses were performed both dividing the sample into two groups (age < or ≥65) and considering age as a continuous quantitative variable. Regression analyses were then performed considering as independent variables only those statistically significant at univariate analyses.

Results: Patients aged ≥ 65 resulted in having longer duration of illness, shorter duration of last antidepressant therapy, higher number of antidepressants assumed in the past, higher frequency of treatment-resistant depression, higher frequency of overweight/obesity and diabetes. As for biochemical parameters, patients ≥ 65 showed lower total plasmatic proteins and albumin, higher uric acid and creatinine.

Conclusions: These preliminary results suggest less effectiveness of antidepressants, more susceptibility to metabolic disorders and poor nutritional status in patients with late-life depression; such aspects may consequently be taken into consideration for a proper therapeutic approach. KEY POINTSDepression in late life seems to be associated with poorer response to antidepressants;Clinicians should prefer compounds with minimal pharmacokinetic interactions and less risk of side effects including metabolic ones;The poor nutritional status and the higher risk of metabolic disorders in older patients points out the importance of proper diet and healthy lifestyle in this group of subjects;Further studies are needed to confirm the results of this research.

引言:晚期抑郁症(MD)是一种常见且代价高昂的精神疾病。我们的目的是检测可能与这种情况相关的临床和生物学因素,以更好地预防和治疗它。方法:我们招募了343名患者,他们因严重抑郁发作连续入住米兰警察诊所和意大利蒙扎ASST的住院诊所。从临床图表中收集了大量的临床和生化变量。进行单变量分析,将样本分为两组(年龄 结果:年龄≥65岁的患者患病时间更长,最后一次抗抑郁治疗的时间更短,过去假设的抗抑郁药数量更高,耐治疗抑郁症的发生频率更高,超重/肥胖和糖尿病的发生频率也更高。在生化参数方面,≥65岁的患者血浆总蛋白和白蛋白较低,尿酸和肌酐较高。结论:这些初步结果表明,在晚期抑郁症患者中,抗抑郁药的有效性较低,更容易发生代谢紊乱,营养状况较差;这些方面因此可以被考虑用于适当的治疗方法。
{"title":"Which clinical factors and biochemical parameters are associated with late-life major depression?","authors":"Massimiliano Buoli,&nbsp;Francesca Legnani,&nbsp;Guido Nosari,&nbsp;Anna Pan,&nbsp;Valentina Ciappolino,&nbsp;Cecilia Maria Esposito,&nbsp;Alessandro Ceresa,&nbsp;Martina Di Paolo,&nbsp;Teresa Surace,&nbsp;Anna Maria Auxilia,&nbsp;Martina Capellazzi,&nbsp;Ilaria Tagliabue,&nbsp;Luisa Cirella,&nbsp;Francesco Zanelli Quarantini,&nbsp;Antonios Dakanalis,&nbsp;Massimo Clerici,&nbsp;Enrico Capuzzi,&nbsp;Alice Caldiroli","doi":"10.1080/13651501.2023.2260426","DOIUrl":"10.1080/13651501.2023.2260426","url":null,"abstract":"<p><strong>Introduction: </strong>Late-life major depression (MD) is a frequent and high-cost psychiatric disorder. Our purpose was to detect clinical and biological factors possibly associated with this condition to better prevent and treat it.</p><p><strong>Methods: </strong>We recruited 343 patients, consecutively admitted for a Major Depressive Episode to the inpatient clinic of Policlinico of Milan and ASST Monza, Italy. A large set of clinical and biochemical variables was collected from clinical charts. Univariate analyses were performed both dividing the sample into two groups (age < or ≥65) and considering age as a continuous quantitative variable. Regression analyses were then performed considering as independent variables only those statistically significant at univariate analyses.</p><p><strong>Results: </strong>Patients aged ≥ 65 resulted in having longer duration of illness, shorter duration of last antidepressant therapy, higher number of antidepressants assumed in the past, higher frequency of treatment-resistant depression, higher frequency of overweight/obesity and diabetes. As for biochemical parameters, patients ≥ 65 showed lower total plasmatic proteins and albumin, higher uric acid and creatinine.</p><p><strong>Conclusions: </strong>These preliminary results suggest less effectiveness of antidepressants, more susceptibility to metabolic disorders and poor nutritional status in patients with late-life depression; such aspects may consequently be taken into consideration for a proper therapeutic approach. KEY POINTSDepression in late life seems to be associated with poorer response to antidepressants;Clinicians should prefer compounds with minimal pharmacokinetic interactions and less risk of side effects including metabolic ones;The poor nutritional status and the higher risk of metabolic disorders in older patients points out the importance of proper diet and healthy lifestyle in this group of subjects;Further studies are needed to confirm the results of this research.</p>","PeriodicalId":14351,"journal":{"name":"International Journal of Psychiatry in Clinical Practice","volume":" ","pages":"359-366"},"PeriodicalIF":3.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41127114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Switching antipsychotics to partial dopamine D2-agonists in individuals affected by schizophrenia: a narrative review. 精神分裂症患者将抗精神病药物转换为部分多巴胺d2激动剂:一项叙述性回顾。
IF 3 4区 医学 Q2 PSYCHIATRY Pub Date : 2023-11-01 Epub Date: 2023-07-10 DOI: 10.1080/13651501.2023.2231047
Pierre Baumann, Philipp Bauknecht, Maxim Kuzin, Georgios Schoretsanitis

Objective: The aim of this review is to analyse the literature regarding studies centred on the clinical outcome of individuals affected by schizophrenia and treated with various antipsychotics, and then switched to orally administered partial D2-dopamine agonists (PD2A): Aripiprazole (ARI), brexpiprazole (BREX) or cariprazine (CARI).

Method: A PubMed literature search was performed on 16 February 2021, and updated on Jan 26, 2022 for literature on antipsychotic switching in individuals affected by schizophrenia. Literature was included from 2002 onward. Six strategies were defined: Abrupt, gradual and cross-taper switch, and 3 hybrid strategies. The primary outcome was all-cause discontinuation rate per switch strategy per goal medication.

Results: In 10 reports on switching to ARI, 21 studies with different strategies were described, but there were only 4 reports and 5 strategies on switching to BREX. Only one study about CARI was included, but it was not designed as a switch study. The studies are difficult to compare due to differences in methodology, previous antipsychotic medication, doses of the introduced P2DA and study duration.

Conclusion: This analysis did not reveal evidence for a preferable switching strategy. A protocol should be developed which defines optimal duration, instruments to be used, and the timing of the exams.KEY MESSAGESMost switch studies on partial D2-agonists focus on ARI, with only a few on BREX, while little is known about the clinical outcome of switching individuals to CARIThere is a wide variation of possible switch methods: Abrupt switch - gradual switch - cross-tapering switch - hybrid strategies including plateau switchThe protocols used differ considerably between the studies. A strict comparison between the studies is difficult, for which reason the present evidence does not support an unambiguous preference for a particular switch strategy.From a methodological point of view, a standardised clinical protocol should be developed to allow comparisons between studies regarding the clinical outcome of individuals switched from one antipsychotic drug to another.

目的:本综述的目的是分析有关研究精神分裂症患者的临床结果的文献,这些患者接受了各种抗精神病药物的治疗,然后改用口服部分D2多巴胺激动剂(PD2A):阿立哌唑(ARI),布瑞哌唑(BREX)或卡哌嗪(CARI)。方法:PubMed于2021年2月16日进行文献检索,并于2022年1月26日更新精神分裂症患者抗精神病药物转换的文献。从2002年起,文献被收录。定义了六种策略:突变、渐进和交叉锥形切换,以及三种混合策略。主要结果是每种切换策略每种目标药物的全因停药率。结果:在10份关于转为ARI的报告中,描述了21项不同策略的研究,但只有4份报告和5份转为BREX的策略。只有一项关于CARI的研究被纳入,但它并不是一项转换研究。由于方法、既往抗精神病药物、引入P2DA的剂量和研究持续时间的差异,这些研究很难进行比较。结论:这项分析并没有揭示出一种更可取的转换策略的证据。应制定一项协议,规定最佳持续时间、使用的仪器和检查时间。关键信息大多数关于部分D2激动剂的切换研究都集中在ARI上,只有少数关于BREX,而对将个体切换到CARI的临床结果知之甚少。可能的切换方法有很大的变化:突然切换-逐渐切换-交叉锥形切换-混合策略,包括平台切换。研究之间使用的方案差异很大。很难对这些研究进行严格的比较,因此,目前的证据并不支持对特定转换策略的明确偏好。从方法学的角度来看,应该制定一个标准化的临床方案,以便对从一种抗精神病药物转为另一种抗心理病药物的个体的临床结果进行比较。
{"title":"Switching antipsychotics to partial dopamine D2-agonists in individuals affected by schizophrenia: a narrative review.","authors":"Pierre Baumann,&nbsp;Philipp Bauknecht,&nbsp;Maxim Kuzin,&nbsp;Georgios Schoretsanitis","doi":"10.1080/13651501.2023.2231047","DOIUrl":"10.1080/13651501.2023.2231047","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this review is to analyse the literature regarding studies centred on the clinical outcome of individuals affected by schizophrenia and treated with various antipsychotics, and then switched to orally administered partial D2-dopamine agonists (PD2A): Aripiprazole (ARI), brexpiprazole (BREX) or cariprazine (CARI).</p><p><strong>Method: </strong>A PubMed literature search was performed on 16 February 2021, and updated on Jan 26, 2022 for literature on antipsychotic switching in individuals affected by schizophrenia. Literature was included from 2002 onward. Six strategies were defined: Abrupt, gradual and cross-taper switch, and 3 hybrid strategies. The primary outcome was all-cause discontinuation rate per switch strategy per goal medication.</p><p><strong>Results: </strong>In 10 reports on switching to ARI, 21 studies with different strategies were described, but there were only 4 reports and 5 strategies on switching to BREX. Only one study about CARI was included, but it was not designed as a switch study. The studies are difficult to compare due to differences in methodology, previous antipsychotic medication, doses of the introduced P2DA and study duration.</p><p><strong>Conclusion: </strong>This analysis did not reveal evidence for a preferable switching strategy. A protocol should be developed which defines optimal duration, instruments to be used, and the timing of the exams.KEY MESSAGESMost switch studies on partial D2-agonists focus on ARI, with only a few on BREX, while little is known about the clinical outcome of switching individuals to CARIThere is a wide variation of possible switch methods: Abrupt switch - gradual switch - cross-tapering switch - hybrid strategies including plateau switchThe protocols used differ considerably between the studies. A strict comparison between the studies is difficult, for which reason the present evidence does not support an unambiguous preference for a particular switch strategy.From a methodological point of view, a standardised clinical protocol should be developed to allow comparisons between studies regarding the clinical outcome of individuals switched from one antipsychotic drug to another.</p>","PeriodicalId":14351,"journal":{"name":"International Journal of Psychiatry in Clinical Practice","volume":" ","pages":"367-384"},"PeriodicalIF":3.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9754680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hospitalisation outcomes for patients with severe mental illness treated by female vs. male psychiatry residents. 女性与男性精神科住院医师治疗严重精神疾病患者的住院结果。
IF 3 4区 医学 Q2 PSYCHIATRY Pub Date : 2023-11-01 Epub Date: 2023-07-20 DOI: 10.1080/13651501.2023.2236162
Amit Yaniv-Rosenfeld, Ariel Rosenfeld, Hagai Maoz

Objective: Recent literature suggests that female physicians provide higher quality of care compared to their male counterparts across a variety of physical medical conditions. We examine whether a similar phenomenon is observed for psychiatry residents treating hospitalised psychiatric patients.

Methods: We analysed 300 hospitalised patient records from Shalvata Mental Healthcare Centre (Hod Hasharon, Israel). Resident-patient sex matchings were compared.

Results: No significant differences were observed in terms of residents' age and patients' age, medical condition and hospitalisation history. Male and female patients treated by female residents presented shorter hospitalisations (58 and 54 days compared to 67 and 66 days, respectively, p < .05), longer time to next hospitalisation (269 and 179 days compared to 179 and 123 days, respectively, p < .01), lower 30-day readmission rate (37% and 35% compared to 10% and 19%, respectively, p < .05), higher levels of family involvement during hospitalisation (2.6 and 2.7 points compared to 2.1 and 1.9 points, respectively, p < .01) and higher chances of obtaining rehabilitation services (39% and 34% vs. 23% and 17%, respectively, p < .05).

Conclusions: Hospitalised patients treated by female psychiatry residents are associated with better hospitalisation outcomes compared to those cared for by male residents. KEY POINTSBoth male and female patients treated by female residents presented better hospitalisation outcomes.These hospitalisation outcomes include shorter hospitalisation periods, longer time to next hospitalisation, lower 30-day remission rate, significantly higher levels of family involvement and higher chances of obtaining rehabilitation services.Further work is needed in order to investigate the sources and reasons for the identified differences.

目的:最近的文献表明,在各种身体状况下,女性医生比男性医生提供更高质量的护理。我们研究了在治疗住院精神病患者的精神病住院患者中是否观察到类似的现象。方法:我们分析了Shalvata精神卫生保健中心(以色列Hod Hasharon)的300份住院患者记录。住院患者的性别匹配进行了比较。结果:住院患者的年龄与患者的年龄、医疗状况和住院史无显著差异。女性住院治疗的男性和女性患者住院时间更短(分别为58天和54天,而67天和66天,p 05),下一次住院时间更长(分别为269天和179天,而179天和123天,p 01),30天再次入院率更低(分别为37%和35%,而10%和19%,p 05,住院期间更高水平的家庭参与(分别为2.6和2.7分,而2.1和1.9分,p 01)和获得康复服务的机会更高(分别为39%和34%,而23%和17%,p 05)男性居民。关键点由女性住院医师治疗的男性和女性患者都表现出更好的住院效果。这些住院结果包括住院时间更短、下次住院时间更长、30天缓解率更低、家庭参与程度明显更高以及获得康复服务的机会更高。还需要进一步的工作来调查所发现差异的来源和原因。
{"title":"Hospitalisation outcomes for patients with severe mental illness treated by female vs. male psychiatry residents.","authors":"Amit Yaniv-Rosenfeld,&nbsp;Ariel Rosenfeld,&nbsp;Hagai Maoz","doi":"10.1080/13651501.2023.2236162","DOIUrl":"10.1080/13651501.2023.2236162","url":null,"abstract":"<p><strong>Objective: </strong>Recent literature suggests that female physicians provide higher quality of care compared to their male counterparts across a variety of physical medical conditions. We examine whether a similar phenomenon is observed for psychiatry residents treating hospitalised psychiatric patients.</p><p><strong>Methods: </strong>We analysed 300 hospitalised patient records from Shalvata Mental Healthcare Centre (Hod Hasharon, Israel). Resident-patient sex matchings were compared.</p><p><strong>Results: </strong>No significant differences were observed in terms of residents' age and patients' age, medical condition and hospitalisation history. Male and female patients treated by female residents presented shorter hospitalisations (58 and 54 days compared to 67 and 66 days, respectively, <i>p < .</i>05), longer time to next hospitalisation (269 and 179 days compared to 179 and 123 days, respectively, <i>p < .</i>01), lower 30-day readmission rate (37% and 35% compared to 10% and 19%, respectively, <i>p < .</i>05), higher levels of family involvement during hospitalisation (2.6 and 2.7 points compared to 2.1 and 1.9 points, respectively, <i>p < .</i>01) and higher chances of obtaining rehabilitation services (39% and 34% vs. 23% and 17%, respectively, <i>p < .</i>05).</p><p><strong>Conclusions: </strong>Hospitalised patients treated by female psychiatry residents are associated with better hospitalisation outcomes compared to those cared for by male residents. KEY POINTSBoth male and female patients treated by female residents presented better hospitalisation outcomes.These hospitalisation outcomes include shorter hospitalisation periods, longer time to next hospitalisation, lower 30-day remission rate, significantly higher levels of family involvement and higher chances of obtaining rehabilitation services.Further work is needed in order to investigate the sources and reasons for the identified differences.</p>","PeriodicalId":14351,"journal":{"name":"International Journal of Psychiatry in Clinical Practice","volume":" ","pages":"338-343"},"PeriodicalIF":3.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9899438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treating postpartum affective and/or anxiety disorders in a mother-baby day hospital: preliminary results. 在母婴日间医院治疗产后情感和/或焦虑障碍:初步结果
IF 3 4区 医学 Q2 PSYCHIATRY Pub Date : 2023-11-01 Epub Date: 2023-08-02 DOI: 10.1080/13651501.2023.2236169
Alba Roca-Lecumberri, Anna Torres, Susana Andrés, Cristina López, Carmen Naranjo, Ester Roda, Lluïsa Garcia-Esteve, Estel Gelabert

Introduction: Women experiencing perinatal mental-health illness have unique needs. The present study analyzes preliminary data about the effectiveness of MBDH in treating postpartum women with affective and anxiety disorders.

Methods: We analysed 33 mothers with affective and/or anxiety disorders treated at the MBDH with their babies between March 2018 and December 2019. All women were assessed at admission, discharge and three months after discharge. Outcomes included symptoms of depression (EPDS) and anxiety (STAI-S), mother-infant bonding (PBQ) and functional impairment (HoNOs). We also assessed the clinical significance of changes in patients' scores on these scales and patient satisfaction.

Results: At discharge, no patients still met the full criteria for the main diagnosis. Between admission and discharge, symptoms of depression and anxiety, mother-infant bonding, functional impairment and autonomy in caring for babies improved significantly. These gains were maintained at three months follow-up. Patient satisfaction was high.

Conclusions: These preliminary results suggest that multidisciplinary intervention for postpartum women with affective or anxiety disorders at the MBDH improves maternal psychopathology, mother-infant bonding and mothers' ability to care for their babies. MBDHs are a promising approach for delivering specialised perinatal mental-health care for mother-baby dyads.

引言:患有围产期心理健康疾病的妇女有着独特的需求。本研究分析了MBDH治疗产后情感和焦虑障碍妇女的有效性的初步数据。方法:我们分析了2018年3月至2019年12月期间在MBDH接受治疗的33名患有情感和/或焦虑障碍的母亲及其婴儿。所有女性在入院、出院和三个月时都接受了评估 出院后数月。结果包括抑郁(EPDS)和焦虑(STAI-S)症状、母婴结合(PBQ)和功能损害(HoNO)。我们还评估了患者在这些量表上的评分变化和患者满意度的临床意义。结果:出院时,没有患者仍然符合主要诊断的全部标准。从入院到出院,抑郁和焦虑症状、母婴关系、功能障碍和照顾婴儿的自主性都有显著改善。这些收益保持在三 随访数月。患者满意度很高。结论:这些初步结果表明,在MBDH对患有情感或焦虑障碍的产后妇女进行多学科干预,可以改善母亲的精神病理学、母婴关系和母亲照顾婴儿的能力。MBDHs是为母婴二人组提供专业围产期心理健康护理的一种很有前途的方法。
{"title":"Treating postpartum affective and/or anxiety disorders in a mother-baby day hospital: preliminary results.","authors":"Alba Roca-Lecumberri,&nbsp;Anna Torres,&nbsp;Susana Andrés,&nbsp;Cristina López,&nbsp;Carmen Naranjo,&nbsp;Ester Roda,&nbsp;Lluïsa Garcia-Esteve,&nbsp;Estel Gelabert","doi":"10.1080/13651501.2023.2236169","DOIUrl":"10.1080/13651501.2023.2236169","url":null,"abstract":"<p><strong>Introduction: </strong>Women experiencing perinatal mental-health illness have unique needs. The present study analyzes preliminary data about the effectiveness of MBDH in treating postpartum women with affective and anxiety disorders.</p><p><strong>Methods: </strong>We analysed 33 mothers with affective and/or anxiety disorders treated at the MBDH with their babies between March 2018 and December 2019. All women were assessed at admission, discharge and three months after discharge. Outcomes included symptoms of depression (EPDS) and anxiety (STAI-S), mother-infant bonding (PBQ) and functional impairment (HoNOs). We also assessed the clinical significance of changes in patients' scores on these scales and patient satisfaction.</p><p><strong>Results: </strong>At discharge, no patients still met the full criteria for the main diagnosis. Between admission and discharge, symptoms of depression and anxiety, mother-infant bonding, functional impairment and autonomy in caring for babies improved significantly. These gains were maintained at three months follow-up. Patient satisfaction was high.</p><p><strong>Conclusions: </strong>These preliminary results suggest that multidisciplinary intervention for postpartum women with affective or anxiety disorders at the MBDH improves maternal psychopathology, mother-infant bonding and mothers' ability to care for their babies. MBDHs are a promising approach for delivering specialised perinatal mental-health care for mother-baby dyads.</p>","PeriodicalId":14351,"journal":{"name":"International Journal of Psychiatry in Clinical Practice","volume":" ","pages":"344-350"},"PeriodicalIF":3.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9911883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Psychiatry in Clinical Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1